The purpose of our study is to investigate the potential correlation between the SGLT2 inhibitors application and the development of corneal disease including superficial keratopathy and infectious keratitis via the data in National Health Insurance Research Database (NHIRD). The gene discussed is SLC5A2; the disease is keratitis.